Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1372358rdf:typepubmed:Citationlld:pubmed
pubmed-article:1372358lifeskim:mentionsumls-concept:C0016411lld:lifeskim
pubmed-article:1372358lifeskim:mentionsumls-concept:C0034407lld:lifeskim
pubmed-article:1372358lifeskim:mentionsumls-concept:C0040085lld:lifeskim
pubmed-article:1372358lifeskim:mentionsumls-concept:C0061472lld:lifeskim
pubmed-article:1372358lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:1372358lifeskim:mentionsumls-concept:C0220781lld:lifeskim
pubmed-article:1372358lifeskim:mentionsumls-concept:C1883254lld:lifeskim
pubmed-article:1372358lifeskim:mentionsumls-concept:C0021469lld:lifeskim
pubmed-article:1372358lifeskim:mentionsumls-concept:C0301869lld:lifeskim
pubmed-article:1372358lifeskim:mentionsumls-concept:C0123106lld:lifeskim
pubmed-article:1372358pubmed:issue5lld:pubmed
pubmed-article:1372358pubmed:dateCreated1992-4-17lld:pubmed
pubmed-article:1372358pubmed:abstractTextThirteen poly-gamma-glutamates derived from several novel antifolates have been synthesized by a convergent route. The syntheses of poly-gamma-glutamyl conjugates of N-[5-[N-(3,4-dihydro-2- methyl-4-oxoquinazolin-6-ylmethyl)-N-methylamino]-2-theno yl]-L-glutamic acid (8) (ICI D1694), 2-desamino-N10-propargyl-5,8-dideazafolic acid (6), 2-desamino-2-methyl-N10-propargyl-5,8-dideazafolic acid (7), 2-desamino-2-methyl-N10-propargyl-2'-fluoro-5,8-dideazafolic acid (9), and 2-desamino-2-methyl-4-chloro-N10-propargyl-2'-fluoro-3,5,8-trideazafo lic acid (11) are described. A key step in the route involves coupling of an alpha-tert-butyl-protected poly-gamma-glutamate of the required chain length to the appropriate 5,8-dideazapteroic acid, obtained by carboxypeptidase G2 cleavage of the parent monoglutamate, if available, or by chemical synthesis. Deprotection with trifluoroacetic acid in the final step gave the desired poly-gamma-glutamyl antifolates as their trifluoroacetate salts. As inhibitors of thymidylate synthase, these polyglutamates were more potent in every case than the corresponding non-polyglutamylated drug.lld:pubmed
pubmed-article:1372358pubmed:languageenglld:pubmed
pubmed-article:1372358pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1372358pubmed:citationSubsetIMlld:pubmed
pubmed-article:1372358pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1372358pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1372358pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1372358pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1372358pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1372358pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1372358pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1372358pubmed:statusMEDLINElld:pubmed
pubmed-article:1372358pubmed:monthMarlld:pubmed
pubmed-article:1372358pubmed:issn0022-2623lld:pubmed
pubmed-article:1372358pubmed:authorpubmed-author:CalvertA HAHlld:pubmed
pubmed-article:1372358pubmed:authorpubmed-author:HughesL RLRlld:pubmed
pubmed-article:1372358pubmed:authorpubmed-author:BissetG MGMlld:pubmed
pubmed-article:1372358pubmed:authorpubmed-author:JackmanA LALlld:pubmed
pubmed-article:1372358pubmed:authorpubmed-author:PawelczakKKlld:pubmed
pubmed-article:1372358pubmed:issnTypePrintlld:pubmed
pubmed-article:1372358pubmed:day6lld:pubmed
pubmed-article:1372358pubmed:volume35lld:pubmed
pubmed-article:1372358pubmed:ownerNLMlld:pubmed
pubmed-article:1372358pubmed:authorsCompleteYlld:pubmed
pubmed-article:1372358pubmed:pagination859-66lld:pubmed
pubmed-article:1372358pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:1372358pubmed:meshHeadingpubmed-meshheading:1372358-...lld:pubmed
pubmed-article:1372358pubmed:meshHeadingpubmed-meshheading:1372358-...lld:pubmed
pubmed-article:1372358pubmed:meshHeadingpubmed-meshheading:1372358-...lld:pubmed
pubmed-article:1372358pubmed:meshHeadingpubmed-meshheading:1372358-...lld:pubmed
pubmed-article:1372358pubmed:meshHeadingpubmed-meshheading:1372358-...lld:pubmed
pubmed-article:1372358pubmed:meshHeadingpubmed-meshheading:1372358-...lld:pubmed
pubmed-article:1372358pubmed:year1992lld:pubmed
pubmed-article:1372358pubmed:articleTitleSyntheses and thymidylate synthase inhibitory activity of the poly-gamma-glutamyl conjugates of N-[5-[N-(3,4-dihydro-2-methyl-4-oxoquinazolin-6-ylmethyl)-N-methylamino ]-2-thenoyl]-L-glutamic acid (ICI D1694) and other quinazoline antifolates.lld:pubmed
pubmed-article:1372358pubmed:affiliationInstitute of Cancer Research, Cancer Research Campaign Laboratories, Sutton, Surrey, England.lld:pubmed
pubmed-article:1372358pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1372358pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:1372358lld:chembl
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1372358lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1372358lld:pubmed